CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Head & Neck Cancer

ONCOLOGY. Vol. 9 No. 6
Pages: 1  2  3  
Next
REVIEW ARTICLE 

Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

By Scott P. Stringer, MD1 | May 31, 1995
1 Department of Otolaryngology, University of Florida College of Medicine, Gainesville, Florida

ABSTRACT: The surgical management of neck metastases from head and neck cancer consists primarily of neck dissection. An awareness of both the cervical anatomy and natural history of squamous cell carcinoma of the upper aerodigestive tract is necessary to understand the role of neck dissection and to appreciate when it may be appropriate to modify the standard radical neck dissection. The use of imaging to augment palpation of the neck has resulted in greater accuracy in identifying neck metastases and has further clarified the role of modified neck dissections. Depending on the site and size of the primary tumor, radiation therapy, modified neck dissection, or selective neck dissection are all appropriate options for the elective treatment of the neck when there is a high risk of occult metastasis. Therapeutic neck dissection alone is adequate for early-stage neck disease, but must be combined with irradiation for more advanced stages. Regional control of tumor metastases is highly dependent on the stage of neck disease and the presence of extranodal cancer spread. [ONCOLOGY 9(6):547-558, 1995]

Introduction

Radical neck dissection, first described by Crile in 1906 [1], is the standard against which all surgical approaches to neck metastases is compared. Consideration was subsequently given to more conservative surgical techniques, but they did not gain widespread acceptance and were condemned by Martin et al in the 1950s [2].

(MORE: Commentary (Goodwin): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer)

Surgical management of the neck has continued to evolve toward more conservative approaches, however. Even selective neck dissection techniques are now widely accepted. Current controversies center around the appropriate use of modified and selective neck dissections, indications for elective neck treatment, and selection of the best therapeutic modality for elective neck treatment. This article will address these as well as other surgical considerations, and will review the surgical techniques currently available for neck treatment.

Anatomic Considerations

A neck dissection is, in fact, an anatomic dissection of the neck. Therefore, a clear grasp of the anatomy of the cervical lymph node groups and cervical aponeurotic system is essential for proper understanding of neck dissection.

FIGURE 1 Lymph node groups are most commonly referred to by the names in this illustration.
Lymph node groups are most commonly referred to by the names in this illustration.
FIGURE 2 Lymph node groups are subdivided for ease of communication into levels as demonstrated by this figure.
Lymph node groups are subdivided for ease of communication into levels as demonstrated by this figure.

Cervical Lymph Node Groups

There are approximately 150 to 350 lymph nodes above the clavicles. Since the lymphatic system is embryologically related to the venous system, the lymph nodes are closely related to veins. The cervical lymph nodes have commonly been divided into surgical levels to facilitate discussions of patterns of metastases and types of neck dissection (Figures 1 and 2).

The submandibular and submental nodes constitute the level I group. The submental lymph nodes are located in the midline within the triangle defined by the anterior bellies of the digastric muscles and the hyoid bone. The submandibular nodes are situated within a triangle bounded by the anterior and posterior bellies of the digastric muscle and the mandibular body. These nodes are in close relationship to the submandibular gland and the posterior facial vein. Notably, the gland itself does not include any lymph nodes.

The internal jugular vein lymph nodes are limited anteriorly by the lateral margin of the sternohyoid muscle and posteriorly by the posterior border of the sternocleidomastoid muscle, and are subdivided into three groups. The level II group, or upper internal jugular nodes, extend from the skull base superiorly to the hyoid bone or carotid bifurcation inferiorly. These nodes , also commonly referred to as jugulodigastric nodes, are closely related to the superior portion of the spinal accessory nerve as well. The middle jugular group (level III group) continues inferiorly to the omohyoid muscle. The lower jugular group (level IV) nodes extend from the omohyoid muscle to the level of the clavicle.

The level V group, or posterior triangle lymph nodes, are bounded by the posterior edge of the sternocleidomastoid muscle, anterior border of the trapezius muscle, and clavicle. Superiorly, these nodes closely approximate the spinal accessory nerve, and are often referred to as the spinal accessory chain. The nodes that are located near the confluence of the posterior triangle and upper jugular groups are sometimes termed junctional nodes. The supraclavicular nodes are part of the posterior triangle group.

The anterior compartment group (level VI) is bounded superiorly by the hyoid bone, inferiorly by the sternum, and laterally by the common carotid arteries. Included in this group are the paratracheal, pretracheal, precricoid (Delphian), and tracheoesophageal groove nodes.

Additional groups that are sometimes dissected outside the normally described boundaries of the neck include the facial, parotid, preauricular, retroauricular, suboccipital, and retropharyngeal nodes.

FIGURE 3 The contents of the neck are divided into several spaces by a variety of fascial interconnections. These spaces and fascial layers are demonstrated in this figure.
The contents of the neck are divided into several spaces by a variety of fascial interconnections. These spaces and fascial layers are demonstrated in this figure.

Cervical Aponeurotic System

The cervical aponeurotic system divides the neck into compartments, including the lateral and paravisceral spaces, that are removed with a neck dissection (Figure 3). The superficial cervical fascia is a thin layer that invests the platysma muscle. The deep cervical fascia is subdivided into three layers: investing (superficial), pretracheal (middle), and prevertebral (deep).

The investing layer completely encircles the neck, splitting to enclose the sternocleidomastoid, omohyoid, and trapezius muscles. Superiorly, the investing fascia splits to enclose the subman- dibular and parotid glands, and attaches to the lower border of the mandible. The pretracheal layer encompasses the trachea, thyroid gland, and esophagus.

The prevertebral layer covers the prevertebral, scalene, levator scapulae, splenius, and semispinalis capitis muscles, and constitutes the floor of the lateral neck. The phrenic nerve, brachial plexus, sympathetic trunk, and dorsal scapular nerve all lie deep to the prevertebral fascia.

The carotid sheath consists of all three layers of deep cervical fascia and contains the carotid artery and vagus nerve. The jugular vein is located within an extension of the carotid sheath as well.

Critical to an understanding of modified and selective neck dissections is the concept that the lymph nodes lie within the lateral and paravisceral spaces, not within the fascial wrappings of the muscles or the carotid artery. The lymph nodes may, however, be in very close association with these fascial layers. The spinal accessory nerve must be uniquely considered in neck dissection, as it actually travels through the lateral space of the neck just deep to the investing fascia and superficial to the prevertebral fascia.

Tumor Biology

Squamous cell carcinoma of the upper aerodigestive tract is the most common tumor to metastasize to the cervical nodes. Less commonly, neck dissection is performed for malignant neoplasms of the thyroid gland, parotid gland, or skin. Distant metastases from below the clavicle occur, but neck dissection is generally of no benefit in the management of these neoplasms.

Once a metastasis reaches a lymph node, tumor growth results in an indurated and more rounded node. Increasing size of the lymph node is directly associated with increased risk of tumor invasion through the capsule, and eventually, fixation to adjacent structures.

The risk of cervical metastases from different primary sites and stages has been estimated by examining the percentage of patients with similar stage tumors who present with clinically positive node [3], the distribution of pathologically positive nodes in an electively dissected, clinically negative neck, and failure rates in untreated necks. In this fashion, the relative risk of cervical metastases may be approximated for specific sites. For example, the glottis has a low risk of metastasizing to the neck(< 20%), whereas the nasopharynx has a high risk (> 30%). Finally, lesions such as early supraglottic laryngeal tumors are considered to be of intermediate risk (20% to 30%) [4].

In many cases, these fairly consistent patterns of metastases allow for the application of selective removal of nodal groups for specified lesions. There are, however, situations in which the normal pattern of nodal metastases do not hold. For example, the right and left sides of the cervical lymphatic system normally do not shunt. However, previous neck surgery, prior irradiation, or multiple positive nodes obstructing the lymphatic system may alter the patterns of cervical metastases such that shunting across the submental region occurs, or unusual nodal groups are involved for a given primary. Furthermore, recurrent lesions are associated with a higher risk of cervical metastasis.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This article reviewed

Commentary (Schuller): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer

Commentary (Goodwin): Current Concepts in Surgical Management of Neck Metastases from Head and Neck Cancer






 
RELATED CONTENT

Study: Recurrent Heartburn Ups Risk for Throat Cancer
May 28, 2013
Parotid Gland Swelling in 45-Year-Old Patient
May 6, 2013
Status of HPV-Related Cancers and Vaccination Trends
February 21, 2013
A 53-Year-Old Man Presents With Painful Neck Swelling
August 30, 2012
Laryngeal Mass Discovered in 46-Year-Old Man
July 23, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Head And Neck Cancer
Evidence on Head And Neck Cancer
Guidelines on Head And Neck Cancer
Patient Education on Head And Neck Cancer
Clinical Trials on Head And Neck Cancer
Practical Articles on Head And Neck Cancer
Research and Reviews on Head And Neck Cancer
All "Head And Neck Cancer" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy